Terlipressin PCD Pharma Franchise Company

Cafoli Lifecare offers a Terlipressin PCD pharma franchise backed by 1 injection formulation, manufactured at WHO-GMP certified facilities with DCGI-approved composition. Terlipressin is a prescription-only hospital injectable, supplied strictly to partners holding a valid Drug License, and is aimed at liver units, ICUs and emergency departments.

What is Terlipressin?

Terlipressin is a synthetic analogue of vasopressin and acts as a prodrug, releasing lysine-vasopressin slowly after administration. Acting on V1 receptors it causes splanchnic vasoconstriction, which reduces portal venous inflow and therefore lowers portal pressure. This is the basis of its use in portal hypertensive bleeding, and its slow release gives it a longer duration of action than vasopressin with a more favourable side-effect profile. Compound information is catalogued on PubChem.

Therapeutic Applications of Terlipressin

Terlipressin is used in the emergency management of acute bleeding from oesophageal varices in portal hypertension, and in hepatorenal syndrome, a serious form of kidney failure occurring in advanced cirrhosis. It is also used in selected cases of refractory septic shock. It is administered by hepatologists, gastroenterologists, intensivists and emergency physicians in hospital settings only, and requires close haemodynamic monitoring during administration.

Why Terlipressin is a High-Potential Molecule for Distributors

Terlipressin is a low-volume, high-value line whose demand is driven by hospital protocol rather than individual prescriber preference — which makes it unusually stable once a liver unit or ICU adopts it. India carries a heavy burden of cirrhosis from alcohol, hepatitis B and C, and increasingly from fatty liver disease, and variceal bleeding is one of its most common emergency presentations. Every gastroenterology and critical care unit must therefore keep terlipressin on the shelf. For a distributor with hospital access, it is a premium injectable with minimal price sensitivity and no retail competition, complementing a portfolio otherwise weighted toward chronic oral products.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers genuine district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and complete promotional inputs including visual aids, samples, prescription pads and MR bags. We are trusted by 1000+ franchise partners across India.

References

1. PubChem – Terlipressin compound record
2. PubMed – clinical literature on Terlipressin
3. MedlinePlus – Terlipressin information